Spectrum of Clinical Features in X-Linked Myotubular Myopathy Carriers: An International Questionnaire Study.
Stacha F I ReumersFrederik BraunJennifer L SpillaneJohann BöhmMaartje PenningsMeyke SchoutenAnneke J van der KooiA Reghan FoleyCarsten G BonnemannErik-Jan KamsteegCorrie E ErasmusUlrike Schara-SchmidtHeinz JungbluthNicol C VoermansPublished in: Neurology (2021)
The prevalence of manifesting XL-MTM carriers may be higher than currently assumed, most having a mild phenotype and a wide variety of symptoms. Manifesting carriers are particularly affected by fatigue, limitations of daily activities, pain, and reduced quality of life. Our findings should increase awareness and provide useful information for health care providers and future clinical trials.